248 related articles for article (PubMed ID: 11821334)
1. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.
Gilbert RE; Gras L; Wallon M; Peyron F; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1303-8. PubMed ID: 11821334
[TBL] [Abstract][Full Text] [Related]
2. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.
Gilbert R; Gras L;
BJOG; 2003 Feb; 110(2):112-20. PubMed ID: 12618153
[TBL] [Abstract][Full Text] [Related]
3. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
4. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
Gras L; Gilbert RE; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
[TBL] [Abstract][Full Text] [Related]
5. [Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Di Carlo P; Mazzola A; Romano A; Schimmenti MG; Colicchia P; Bellipanni P; Titone L
Infez Med; 2005 Jun; 13(2):72-8. PubMed ID: 16220026
[TBL] [Abstract][Full Text] [Related]
6. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol.
Gilbert R; Dunn D; Wallon M; Hayde M; Prusa A; Lebech M; Kortbeek T; Peyron F; Pollak A; Petersen E
Epidemiol Infect; 2001 Aug; 127(1):113-20. PubMed ID: 11561963
[TBL] [Abstract][Full Text] [Related]
7. Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Valentini P; Buonsenso D; Barone G; Serranti D; Calzedda R; Ceccarelli M; Speziale D; Ricci R; Masini L
J Perinatol; 2015 Feb; 35(2):90-4. PubMed ID: 25211284
[TBL] [Abstract][Full Text] [Related]
8. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.
Dunn D; Wallon M; Peyron F; Petersen E; Peckham C; Gilbert R
Lancet; 1999 May; 353(9167):1829-33. PubMed ID: 10359407
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
Paquet C; Yudin MH;
J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
[TBL] [Abstract][Full Text] [Related]
11. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
Foulon W; Villena I; Stray-Pedersen B; Decoster A; Lappalainen M; Pinon JM; Jenum PA; Hedman K; Naessens A
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):410-5. PubMed ID: 9988811
[TBL] [Abstract][Full Text] [Related]
12. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.
Picone O; Fuchs F; Benoist G; Binquet C; Kieffer F; Wallon M; Wehbe K; Mandelbrot L; Villena I
J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101814. PubMed ID: 32428782
[TBL] [Abstract][Full Text] [Related]
13. [Toxoplasma infections in early pregnancy: consequences and management].
Wallon M; Gaucherand P; Al Kurdi M; Peyron F
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
[TBL] [Abstract][Full Text] [Related]
14. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.
Wallon M; Peyron F; Cornu C; Vinault S; Abrahamowicz M; Kopp CB; Binquet C
Clin Infect Dis; 2013 May; 56(9):1223-31. PubMed ID: 23362291
[TBL] [Abstract][Full Text] [Related]
15. [Management of congenital toxoplasmosis in France: current data].
Garcia-Méric P; Franck J; Dumon H; Piarroux R
Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
[TBL] [Abstract][Full Text] [Related]
16. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.
Gras L; Wallon M; Pollak A; Cortina-Borja M; Evengard B; Hayde M; Petersen E; Gilbert R;
Acta Paediatr; 2005 Dec; 94(12):1721-31. PubMed ID: 16421031
[TBL] [Abstract][Full Text] [Related]
17. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
[TBL] [Abstract][Full Text] [Related]
18. Unresolved questions about the most successful known parasite.
Ajzenberg D
Expert Rev Anti Infect Ther; 2011 Feb; 9(2):169-71. PubMed ID: 21342063
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of toxoplasmosis.
Montoya JG; Rosso F
Clin Perinatol; 2005 Sep; 32(3):705-26. PubMed ID: 16085028
[TBL] [Abstract][Full Text] [Related]
20. Commentary: Efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out.
Thulliez P
Int J Epidemiol; 2001 Dec; 30(6):1315-6. PubMed ID: 11821337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
